Antidepressants: mechanism of action, toxicity and possible amelioration

  title={Antidepressants: mechanism of action, toxicity and possible amelioration},
  author={Khushboo Gaur and Balkishan Sharma},
Depression being a state of sadness may be defined as a psychoneurotic disorder characterised by mental and functional activity sadness reduction in activity difficulty in thinking loss of concentration perturbations in appetite sleeping and feelings of dejection hopelessness and generation of suicidal tendencies It is a common and recurrent disorder causing significant morbidity and mortality worldwide The antidepressant compounds used against depression are reported to be used also for… 

Tables from this paper


Preclinical research that supports the potential antidepressant effects of some natural flavonoids, which gives new possibilities of evaluating these substances to develop complementary therapeutic alternatives that could ameliorate symptoms of depressive disorders in humans.

Phytochemicals as Antidepressants

The present chapter illustrates recent advances in research concerning phytochemicals acting as antidepressants as they possess enormous antioxidant potential, easy availability, low cost, least toxicity, and high therapeutic potential.

Antidepressant Screening Demonstrated Non-Monotonic Responses to Amitriptyline, Amoxapine and Sertraline in Locomotor Activity Assay in Larval Zebrafish

Findings indicate that these antidepressants might share a common mechanism responsible for their effects on zebrafish larval locomotor activity although there were some differences in potency of these effects.

Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants.

An overview of structural changes in the brain during depression; different neurobiological theories and novel drug development; strategy of augmentation with combinatorial therapy; receptors and targets of actions of antidepressants; and involvement of key signaling factors in the regulation of depression, pharmacology, metabolism, and the underlying principles involved in displaying how the application of antidepressants modulates the structure and function of the brain are presented.

Factors inducing depression as effective tool in therapy

Depression being a psychological disorder is known to cause morbidity and mortality of the concerned individual globally. According to an estimate from the World Health Organisation (WHO), about 57


This hypothesis can help to elucidate the surprisingly positive results found in the treatment of depression with lactate shuttle and normalise depression-related brain changes.

Neurobehavioural Mechanism of Antidepressant Effect of Methanol Stem Bark Extract of Adansonia digitata (Linn) in Tail Suspension Test in Mice

It is concluded that the methanol stem bark extract of Adansonia digitata may possess antidepressant effect and its mechanism may involve multiple pathways.

Efficacy and Safety of Escitalopram Oral Drops to Treat Major Depressive Disorder and Generalized Anxiety Disorder in Adolescent, Adult and Geriatric Patients: A Prospective Multicenter Observational Study in Pakistan

Escitalopram oral drops are found effective and tolerable in reducing both anxiety and depression over the duration of study in all age groups, including adolescents, adults, and geriatrics.

Anxiety Disorders: Recent Global Approach to Neuro-pathogenesis, Drug Treatment, Cognitive Behavioral Therapy, and Their Implications

This review aimed to appraise the literature on the prevalence, classification, neuro-pathogenesis, diagnoses, and treatment of anxiety disorders (AD).



Modulations of Mammalian Brain Functions by Antidepressant Drugs: Role of Some Phytochemicals as Prospective Antidepressants

An updated account of the understanding about the molecular constituents of the different regions of the brain that control the physiological and behavioural functions of a person, mechanisms of actions of currently available antidepressants and their side effects, if any, as well as the prospects of using phytochemicals as safe and effective alternative medicines are illustrated.

The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans.

The findings that relapse during treatment is specific to the type of treatment and type of depletion, that neither SD or CD produced an increase in clinical depression in healthy controls or depressed patients off medication, and that recovered patients off medications have a return of symptoms following SD, forces a major revision of the current monoamine theories of depression.

Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials.

The authors have concluded that tianeptine is effective in depressive disorders as shown both by depression rating scales and subjective impressions of treated patients, and improvement increases regularly with time.

Risks and Benefits of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression

Current data support a decreased frequency of suicidal ideation with all antidepressants, including selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs), which provides fluoxetine with an overall superior therapeutic profile.

Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.

  • S. Stahl
  • Psychology, Biology
    The Journal of clinical psychiatry
  • 1998
The selective norepinephrine and dopamine reuptake inhibitor bupropion defines a novel class of antidepressant that has no direct actions on the serotonin system.

Modifications of the Serotonin System by Antidepressant Treatments: Implications for the Therapeutic Response in Major Depression

Results of electrophysiological single-cell recording studies suggest that most, if not all, types of antidepressant treatments increase 5-hydroxytryptamine (5-HT) neurotransmission. Tricyclic

Course and treatment of atypical depression.

Monoamine oxidase inhibitors (MAOIs) are superior to tricyclic antidepressants (TCAs) for the treatment of atypical depression, but few studies have compared MAOIs to the newer generation of antidepressants (SSRIs, bupropion, venlafaxine, nefazodone, and mirtazapine).

Drug Treatment of Depression in the 1990s

The most important progress in the past 10 years has been the development of compounds which possess markedly reduced binding capacities at receptor sites not linked to their antidepressive actions.

Evidences for the involvement of monoaminergic and GABAergic systems in antidepressant-like activity of garlic extract in mice

Garlic extract showed significant antidepressant-like activity probably by inhibiting MAO-A andMAO-B levels and through interaction with adrenergic, dopaminergic, serotonergic and GABAergic systems.